Lantus, the new long-acting "peakless" insulin
May 2001
You'll soon be able to prescribe Lantus, the new long-acting "peakless" insulin.
It was approved last year...but Aventis had to postpone the launch until they had an adequate supply.
Lantus is an insulin analog called insulin glargine. It differs from human insulin by 3 amino acids.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote